Skip to content

70. Anxiety that has failed 2 SSRIs: How to switch and which med to choose next with Dr. Strawn

March 31, 2026 · 17 min

Show notes

Send us Fan Mail

SSRI Switching in Pediatrics: When to Try a Third SSRI, When to Use Luvox, and Key Metabolism Pearls

Dr. Elise Fallucco continues her discussion with child psychiatrist Dr. Jeffrey Strawn (University of Cincinnati; co-author of Stahl’s DePrescribing) on practical tips regarding how to stop/decrease an SSRI and switch to another SSRI (or SNRI) for pediatric anxiety.

Highlights from the Episode:

  • After trying 2 different SSRIs for pediatric anxiety, in most cases, it makes sense to try a third SSRI as opposed to an SNRI
    • Rationale: SSRIs tend to be more effective and have fewer side effects than SNRIs
  • "We Don't Talk about LUVOX": Luvox can be a great option for youth with OCD OR anxiety (generalized, social, separation)
    • Dosing strategy: start at 25mg with the plan to titrate up to a target dose of 150-200mg
  • Consider grouping 3 of the SSRIs by their similar metabolic pathways (2C19): Sertraline, Citalopram, and Escitalopram
    • If your patient develops significant side effects on a low dose of one of these 3 meds, they MIGHT be a 2C19 poor metabolizer, which means that you may want to avoid trials of the other 2C19 meds in the group
  • Fluoxetine has a LOOOOONg half-life: and it's related 2D6 inhibition will persist 4–5 weeks after stopping Fluoxetine - and affect the metabolism of other 2D6-metabolized meds during that time
    • The 2D6 group includes meds like Fluoxetine, Paroxetine and 2 of the SNRIs: Duloxetine and Venlafaxine

-- And Check Out Dr. Jeffrey Strawn's new book which I highly recommend - Stahl's Deprescriber's Guide available on Amazon!

00:00 Introduction of Dr. Jeffrey Strawn

00:38 Preview of Episode: Switching SSRIs, when to use FluVOXamine or SNRIs, plus 2D6 and 2C19 metabolism of antidepressant medication

01:59 Try 2 different SSRIs or Duloxetine?

03:45 CYP 2D6 Inhibition with Fluoxetine

04:28 Clinical Pearl: Fluoxetine 2D6 inhibition continues 4-5 weeks after stopping

05:05 2D6 Metabolized Antidepressants: Venlafaxine, Duloxetine, Paroxetine

05:31 Choosing a Third SSRI

05:48 SSRIs generally more effective, fewer side effects than SRNIs in youth

06:49 Only 1 SNRI for child anxiety

07:27 People forget about Fluvoxamine

08:30 Sertraline and Es/Citalopram 2C19 metabolism

09:32 Fluoxetine to FluVOXamine cross-titration

11:16 Gratitude for Dr. Strawn

11:31 Check out Stahl's DEPrescribing Guide

12:23 Recap of Advanced SSRI and SNRI case discussion

Sign-up for our NEWSLETTER

Check out PsychEd4Peds.com for more resources!

SOCIAL @psyched4peds

On-demand CME Course online at: Pediatric Mental Health CME Toolkit - Cracking the ADHD Code: Essentials for Pediatric Clinicians.

All episodes of ADHD, Anxiety & More: Child Mental Health for Pediatrics

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.